Table 4 Kallman syndrome: data from Presidia in Tuscany
Single presidium RTMR data | All presidia RTMR data | Single presidium % | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Presidium (Healthcare Company-Department/Unit) | Tot CASES FROM 2000 (FD OR CONT) | Residents | Tot CASES from 2014 (FD OR CONT) | Residents (%) | Tot CERT FROM 27/5/17 | Tot TP from 27/5/17 | Tot CASES | Tot CERT | TOT TP | % CASES | % CERT | % TP | |
Presidium 1 | Endocrinology and andrology | 29 | 26 | 18 | 94 | 3 | 1 | 62 | 16 | 17 | 29.0 | 18.8 | 5.9 |
Presidium 1 | Genetics | 2 | 2 | 1 | 100 | 0 | 0 | 62 | 16 | 17 | 1.6 | 0.0 | 0.0 |
Presidium 1 | Endocrinology | 8 | 7 | 2 | 50 | 1 | 1 | 62 | 16 | 17 | 3.2 | 6.3 | 5.9 |
Presidium 1 | Pediatric gynecology | 3 | 2 | 1 | 100 | 0 | 0 | 62 | 16 | 17 | 1.6 | 0.0 | 0.0 |
Presidium 2 | Endocrinology 1 | 7 | 2 | 3 | 33 | 0 | 0 | 62 | 16 | 17 | 4.8 | 0.0 | 0.0 |
Presidium 2 | Endocrinology 2 | 11 | 6 | 11 | 55 | 8 | 8 | 62 | 16 | 17 | 17.7 | 50.0 | 47.1 |
Presidium 2 | Molecular genetics | 9 | 2 | 9 | 22 | 0 | 0 | 62 | 16 | 17 | 14.5 | 0.0 | 0.0 |
Presidium 2 | Clinical genetics | 1 | 1 | 1 | 100 | 0 | 0 | 62 | 16 | 17 | 1.6 | 0.0 | 0.0 |
Presidium 2 | Pediatric endocrinology | 4 | 3 | 3 | 100 | 3 | 7 | 62 | 16 | 17 | 4.8 | 18.8 | 41.2 |
Presidium 3 | Congenital bone diseases | 1 | 1 | 1 | 100 | 1 | 0 | 62 | 16 | 17 | 1.6 | 6.3 | 0.0 |
Presidium 3 | Genetics | 8 | 6 | 2 | 100 | 0 | 0 | 62 | 16 | 17 | 32 | 0.0 | 0.0 |
Presidium 4 | Genetics | 1 | 1 | 1 | 100 | 0 | 0 | 62 | 16 | 17 | 1.6 | 0.0 | 0.0 |